TEXT-EXTRACT 2 filename2.txt United States securities and exchange commission logo June 1, 2022 Mark Baum Chief Executive Officer and Chairman of the Board HARROW HEALTH, INC. 102 Woodmont Blvd., Suite 610 Nashville, Tennessee 37205 Re: HARROW HEALTH, INC. Registration Statement on Form S-3 Filed May 26, 2022 File No. 333-265244 Dear Mr. Baum: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jay Nixon, Esq.